Julie Roques

Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma

Fabienne Guillaumond, Ghislain Bidaut, Mehdi Ouaïssi et al. · Proceedings of the National Academy of Sciences · 2015 · 464 citations · Full text

Medicine, Oncology, Pharmacology +17

Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions

O. Porta Olivares, Jared R. Mayers, Victoire Gouirand et al. · Nature Communications · 2017 · 402 citations · Full text

Life Sciences, Cell Biology, Oncology +15

Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness

Julie Leca, Sébastien Martinez, Sophie Lac et al. · Journal of Clinical Investigation · 2016 · 212 citations · Full text

Medicine, Cell Biology, Oncology +17

Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts

Rémy Nicolle, Yuna Blum, Laëtitia Marisa et al. · Cell Reports · 2017 · 196 citations · Full text

Medicine, Cancer Biology, Oncology +17

Basal‐like and classical cells coexist in pancreatic cancer revealed by single‐cell analysis on biopsy‐derived pancreatic cancer organoids from the classical subtype

Natalia Juiz, Abdessamad El-Kaoutari, Martin Bigonnet et al. · The FASEB Journal · 2020 · 146 citations

Medicine, Cell Biology, Oncology +17